Berenberg Bank assumed coverage on shares of Novozymes A/S (OTCMKTS:NVZMY) in a report published on Tuesday, StockTargetPrices.com reports. The firm issued a sell rating on the stock.
Shares of Novozymes A/S (OTCMKTS:NVZMY) opened at 43.21 on Tuesday. The stock’s 50 day moving average price is $43.54 and its 200 day moving average price is $46.05. The firm has a market capitalization of $12.98 billion, a price-to-earnings ratio of 30.24 and a beta of 0.70. Novozymes A/S has a one year low of $37.98 and a one year high of $49.55.
Novozymes A/S Company Profile
Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. In June 2013, the Company restructured its sales areas within those segments. The Household Care (old Household Care Enzymes) area comprises cleaning solutions, laundry, dishwashing and microorganism sales for cleaning solutions.
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.